 | | PRD_000865 | | Name: | N-[(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-a
lanyl-L-alaninamide | | Formula: | C31 H31 Br Cl N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000866 | | Name: | N-{(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alpha-glutamyl-L-al
pha-glutamine | | Formula: | C29 H32 Br N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000868 | | Name: | N-{(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alanyl-L-alaninamid
e | | Formula: | C25 H28 Br N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000908 | | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1S)-2-phenyl-1-phosphonoethyl]-L-prolinamide | | Formula: | C22 H32 N3 O8 P | | Definition date: | 2013-01-23 | | Last modified: | 2013-01-23 |
|
 | | PRD_000958 | | Name: | tert-butyl {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-amino-1-cyclopropyl-3-hydroxy-4-oxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | | Formula: | C26 H44 N4 O6 | | Definition date: | 2012-12-26 | | Last modified: | 2012-12-26 |
|
 | | PRD_000920 | | Name: | SAMAROSPORIN I | | Formula: | C77 H120 N16 O19 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000944 | | Name: | N-{(2S)-1-[(2-chlorobenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[3-(2-methylphenyl)propanoyl]-L-threoninamide | | Formula: | C31 H36 Cl N3 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000946 | | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-isoleucinamide | | Formula: | C30 H42 N4 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000947 | | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(cyclohexylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | | Formula: | C31 H35 N3 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000948 | | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(3-phenylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | | Formula: | C33 H33 N3 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000949 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-([(2S)-2-methylbutyl]{[5-(1,2-oxazol-5-yl)thiophen-2-yl]sulfonyl}amino)-1-phenylbutan-2-yl]benzamide | | Formula: | C29 H33 N3 O6 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000950 | | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-leucinamide | | Formula: | C30 H42 N4 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000951 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]benzamide | | Formula: | C28 H34 N2 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000952 | | Name: | N~2~-acetyl-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]-L-isoleucinamide | | Formula: | C29 H43 N3 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000953 | | Name: | N-[(2S,3R)-4-{(cyclohexylmethyl)[(4-methoxyphenyl)sulfonyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-3-hydroxybenzamide | | Formula: | C31 H38 N2 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000954 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](3-phenylpropyl)amino}-1-phenylbutan-2-yl]benzamide | | Formula: | C33 H36 N2 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000955 | | Name: | 3-hydroxy-N-{(2S,3R)-3-hydroxy-4-[(2-methylpropyl){[5-(1,2-oxazol-5-yl)thiophen-2-yl]sulfonyl}amino]-1-phenylbutan-2-yl}benzamide | | Formula: | C28 H31 N3 O6 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000959 | | Name: | 4-(benzyloxy)-N-[(2S,3R)-3-hydroxy-1-{[(2S)-1-{[(3-methylthiophen-2-yl)methyl]amino}-1-oxo-4-phenylbutan-2-yl]amino}-1-oxobutan-2-yl]benzamide | | Formula: | C34 H37 N3 O5 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000971 | | Name: | N-acetylglycyl-N-[(3S)-1-hydroxy-5-methyl-2-oxohexan-3-yl]-L-serinamide | | Formula: | C14 H25 N3 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000991 | | Name: | 1,2,4-trideoxy-4-methyl-2-{[N-(morpholin-4-ylacetyl)-L-alanyl-O-methyl-L-tyrosyl]amino}-1-phenyl-D-xylitol | | Formula: | C31 H44 N4 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001003 | | Name: | N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide | | Formula: | C32 H45 N5 O3 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001011 | | Name: | (3S)-4-hydroxy-3-{[(2S)-4-{[2-(2-methyl-1H-benzimidazol-1-yl)ethyl]amino}-2-(1-methylethyl)-4-oxobutanoyl]amino}butanoic acid | | Formula: | C21 H30 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001017 | | Name: | (S)-N-((1R,2S)-1-((2R,3R)-3-benzyloxiran-2-yl)-1-hydroxy-3-phenylpropan-2-yl)-3-methyl-2-(2-phenoxyacetamido)butanamide | | Formula: | C31 H36 N2 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001019 | | Name: | (S)-N-((2S,3S,4R,5R)-4-amino-3,5-dihydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-phenoxyacetamido)butanamide | | Formula: | C31 H39 N3 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001032 | | Name: | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4-DIONYL]-ISOLEUCYL-PROLINE | | Formula: | C18 H31 N3 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
